Reni Benjamin's questions to Beigene Ltd (ONC) leadership • Q4 2024
Question
Reni Benjamin from Citizens JMP asked about the recently completed enrollment of the CELESTIAL study and sought details on expected event rates, the timeline for top-line data, and a potential NDA submission.
Answer
CEO John Oyler highlighted the rapid 14-month enrollment as a demonstration of strong clinical execution. He confirmed the study is event-driven with a PFS endpoint but did not provide a specific timeline for the data readout, noting that the control arm's data will take time to mature.